Integrating Oncolytic Virotherapy into Immunotherapy Combinations to Overcome Resistance to Immune Checkpoint Inhibitors
Time: 3:00 pm
day: Day Two
Details:
- ICIs have been integrated into many tumor types and have become the backbone of many cancer treatments
- Response to ICI is limited due to ‘cold tumors’ and development of resistance
- Oncolytic viruses are able to change the tumour microenvironment and may provide a solution for patients who are ICI-refractory
